# Biohit Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biohit-healthcare

- Industry: Medical Devices & Equipment
- Headquarters: Hefei, China
- Website: www.biohit.cn
- Latest round: Series A (Jan 12, 2018)
- Investors on record: 1

## About

Founded in 2013 and based in Hefei, China, Biohit Healthcare operates as a medical company that focuses on the research and development of diagnostic instruments and reagents. It was recognized as the National High-tech Enterprise. In September 2019, Biohit Healthcare raised strategic investment from new investors Hefei Chuangtou and HighLight Capital. In 2023, the company established a medical testing laboratory.

The company is mainly engaged in the research and development, production, and sales of in vitro diagnostic reagents and supporting instruments. It provides users with testing instrument maintenance and diagnostic testing services. Its products include 3 types of serum gastric function enzyme-linked immunosorbent assay kits such as G-17, serum gastric function reagents and instruments, COVID-19 antigen and antibody tests, etc.

The company generates revenue by selling in vitro diagnostic reagents and supporting instruments.

## Funding rounds

- Series A, Jan 12, 2018 — CD Capital

## Investors

- CD Capital — Series A